德国表示,尽管BioNTech遭遇生产损失,疫苗供应仍得到保障

路透中文
May 06
德国表示,尽管BioNTech遭遇生产损失,疫苗供应仍得到保障

路透柏林5月6日 - 德国政府一名发言人周三表示,该国因BioNTech疫苗停产造成的缺口可由其他公司弥补。

他补充说,政府仍认为民众的疫苗供应有保障。

BioNTech本周表示 (link),由于这家新冠疫苗制造商正逐步退出疫情期间的疫苗生产,将关闭部分生产基地,此举将导致多达1,860个岗位受影响。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10